T2-FLAIR Mismatch: An Imaging Biomarker for Children’s<i>MYB/MYBL1</i>–Altered Diffuse Astrocytoma or Angiocentric Glioma
Emiel A. van Maren(Utrecht University), Maarten H. Lequin(McDonald's (United States)), Jan Willem Dankbaar(University of Groningen), Angelika Mühlebner(Utrecht University), Mariëtte E.G. Kranendonk(Princess Máxima Center), Tom J. Snijders(University Medical Center Utrecht), Eelco W. Hoving(Princess Máxima Center), Pieter Wesseling(Radboud University Nijmegen), Raoull Hoogendijk, Sabine Plasschaert(Princess Máxima Center), Pierre A. Robe(University Medical Center Utrecht)
Cited by 12
Related Papers
Overcoming the blood–brain tumor barrier for effective glioblastoma treatment
|Drug Resistance Updates|2015|1k
<scp>WHO</scp> 2016 Classification of gliomas
|Neuropathology and Applied Neurobiology|2017|817
Diffuse glioma growth: a guerilla war
|Acta Neuropathologica|2007|640
EANO–ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumours
|Annals of Oncology|2021|577
Mouse telomerase reverse transcriptase (mTert) expression marks slowly cycling intestinal stem cells
|Proceedings of the National Academy of Sciences|2010|532